Gabapentin–Baclofen Coma Case Improved After Flumazenil Without Proving Benzodiazepine Exposure

A reversal response alone did not identify the responsible drug or receptor mechanism.

What the source reports

The report described profound unresponsiveness during gabapentin and baclofen treatment after spinal injury. Routine neurological and physiological investigations were unrevealing, and consciousness returned after flumazenil. The authors proposed further investigation of possible mechanisms beyond its conventional antagonist role.

Limits and uncertainty

The attribution to gabapentin was based on one uncontrolled clinical course with concurrent baclofen. A temporal response does not prove a specific molecular interaction or establish a generally effective antidote. Spontaneous fluctuation and unmeasured contributors remain considerations.

Application to expert review

For a forensic opinion, document the complete administration and diagnostic timeline. Do not infer an undisclosed benzodiazepine solely from a flumazenil response, or treat this unusual case as proof that flumazenil reliably reverses all gabapentin toxicity. Mechanistic certainty requires evidence beyond clinical sequence.

Source and related reading

Source: Publication PMC8106827. Applications to expert review are interpretive analysis.